Ellis Ophthalmic Technologies, Inc

Ellis Ophthalmic Technologies manufactures intraocular lenses (IOLs) for cataract surgery and refractive correction. The company produces multiple IOL designs including foldable hydrophilic monofocal and multifocal lenses, foldable hydrophobic lenses, and rigid PMMA lenses. Their product portfolio includes the M-DIFF multifocal IOL utilizing diffractive-refractive combined technology, hydrophobic IOLs with proprietary posterior edge design, and monofocal foldable acrylic lenses available in open and closed haptic configurations. All lenses incorporate a natural yellow chromophore to block harmful ultraviolet and blue light. The company implements rigorous quality control protocols using IOLA-MFD testing for diffraction analysis, modulation transfer function (MTF) assessment, and Airforce target methods. Ellis serves ophthalmologists and cataract surgeons globally. IOLs are supplied for implantation in presbyopic and non-presbyopic patients seeking vision correction post-cataract removal. The company emphasizes biocompatibility, optical design innovation, and manufacturing precision in foldable and rigid acrylic lens platforms.